Rare diseases
Investigational molecules
Locations
Back to Spain309 clinical trials in Las Palmas De Gran Canaria, Spain across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
SpainStudy on the Long-Term Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa
SpainStudy Comparing Selpercatinib with a Drug Combination for Patients with Advanced RET Fusion-Positive Non-Small Cell Lung Cancer
SpainStudy of Chemotherapy vs. Nivolumab for Patients with Resectable Non-Small Cell Lung Cancer
SpainStudy on Tiragolumab and Atezolizumab for Patients with Resected Stage IIB-IIIB Non-Small Cell Lung Cancer After Chemotherapy
SpainStudy of Nivolumab and Ipilimumab with Chemotherapy for Patients with Stage IV Non-Small Cell Lung Cancer and Brain Metastases
SpainStudy of Tarlatamab for Patients with Limited-Stage Small-Cell Lung Cancer After Chemoradiotherapy
SpainStudy of Datopotamab Deruxtecan, Durvalumab, and Carboplatin for Advanced Non-Small Cell Lung Cancer in Patients Without Actionable Genomic Alterations
SpainStudy of Tiragolumab, Atezolizumab, and Pembrolizumab for Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer
SpainStudy on the Effectiveness and Safety of Pembrolizumab, Canakinumab, and Chemotherapy for Untreated Advanced Non-Small Cell Lung Cancer Patients
SpainStudy of Chemotherapy and Nivolumab for Patients with Locally Advanced Non-Small Cell Lung Cancer
SpainStudy of Immunotherapy Combinations with GSK4428859, Dostarlimab, and GSK6097608 for Patients with Advanced Non-Small Cell Lung Cancer
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on multiple cancer types, including studies of novel therapeutic approaches for leukemia, lung cancer, and breast cancer.
Research emphasizes combination therapies and targeted treatments to improve patient outcomes.
Comprehensive studies investigating treatments for inflammatory diseases and autoimmune disorders, with particular focus on novel biological therapies.
Advanced clinical trials evaluating new therapeutic approaches for chronic inflammatory conditions.
Cutting-edge research in immunotherapy and allergic conditions, exploring new treatment modalities and therapeutic combinations.
Innovative approaches focusing on immune system modulation for various conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
